Tag: Prostate Cancer
Preliminary results from a University of North Carolina Lineberger Comprehensive Cancer Center study found that just 15 percent of a group of men in North Carolina with early-stage prostate cancer who choose active surveillance instead of treatment followed the recommended monitoring guidelines. The findings, which were presented today at the American Society of Clinical Oncology … Continued
Researchers led by UNC Lineberger’s Ronald C. Chen, MD, MPH, and Justin Trogdon, PhD, examined the costs associated with screening for prostate cancer, including treatment, for three years after diagnosis. They estimated that for men diagnosed in each of 2004, 2005, 2006, and 2007, the total cost for treating and screening for each group would be $1.2 billion for three years after diagnosis.
At the 2018 American Society of Clinical Oncology Annual Meeting, UNC Lineberger’s Ronald Chen, MD, MPH, and colleagues presented findings from a study that assessed whether monitoring prostate cancer patients following treatment with a PSA test every three months versus once a year would provide a long-term survival benefit.